Aarsland D, Laake K, Larsen JP, Janvin C (2002) Donepezil for cognitive impairment in Parkinson’s disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 72(6):708–712
Article
CAS
PubMed
PubMed Central
Google Scholar
Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH (2017) Hippocampal α-Synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci 37(7):1675–1684
Article
CAS
PubMed
PubMed Central
Google Scholar
Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovács GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H (2008) Staging of neurofibrillary pathology in Alzheimer’s disease: a study of the BrainNet Europe Consortium. Brain Pathol 18(4):484–496
PubMed
PubMed Central
Google Scholar
Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe consortium. Acta Neuropathol 117(6):635–652
Article
CAS
PubMed
Google Scholar
American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) [Internet]. American Psychiatric Association
Arellano JI, Muñoz A, Ballesteros-Yáñez I, Sola RG, DeFelipe J (2004) Histopathology and reorganization of chandelier cells in the human epileptic sclerotic hippocampus. Brain 127(Pt 1):45–64
Article
CAS
PubMed
Google Scholar
Armstrong RA, Cairns NJ (2015) Comparative quantitative study of “signature” pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders. J Neural Transm Springer Vienna 122(10):1355–1367
Article
CAS
Google Scholar
Armstrong RA, Kotzbauer PT, Perlmutter JS, Campbell MC, Hurth KM, Schmidt RE, Cairns NJ (2014) A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease. J Neural Transm 121(2):171–181
Article
CAS
PubMed
Google Scholar
Ballard C, Ziabreva I, Perry R, Larsen JP, O’Brien J, McKeith I, Perry E, Aarsland D (2006) Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67(11):1931–1934
Article
CAS
PubMed
Google Scholar
Bartus RT, Dean RL, Beer B, Lippa A (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science. 217(4558):408–414
Article
CAS
PubMed
Google Scholar
Benes FM, Kwok EW, Vincent SL, Todtenkopf MS (1998) A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44(2):88–97
Article
CAS
PubMed
Google Scholar
Blümcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, Bernasconi N, Bien CG, Cendes F, Coras R, Cross JH, Jacques TS, Kahane P, Mathern GW, Miyata H, Moshé SL, Oz B, Özkara Ç, Perucca E, Sisodiya S, Wiebe S, Spreafico R (2013) International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE commission on diagnostic methods. Epilepsia 54(7):1315–1329
Article
PubMed
Google Scholar
Bobinski M, Wegiel J, Tarnawski M, Bobinski M, Reisberg B, de Leon MJ, Miller DC, Wisniewski HM (1997) Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol 56(4):414–420
Article
CAS
PubMed
Google Scholar
Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol. Nature Publishing Group 11(4):301–307
Article
CAS
PubMed
PubMed Central
Google Scholar
Chaudhuri KR, Healy DG, Schapira AHV (2006) National Institute for clinical excellence. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245
Article
PubMed
Google Scholar
Chevaleyre V, Piskorowski RA (2016) Hippocampal area CA2: an overlooked but promising therapeutic target. Trends Mol Med Elsevier Ltd 22(8):645–655
Article
Google Scholar
Churchyard A, Lees A (1997) The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson’s disease. Neurology 49(6):1570–1576
Article
CAS
PubMed
Google Scholar
Compta Y, Parkkinen L, O’Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- and Alzheimer-type pathologies in Parkinson’s disease dementia: which is more important? Brain 134(Pt 5):1493–1505
Article
PubMed
PubMed Central
Google Scholar
Cui Z, Gerfen CR, Young WS (2013) Hypothalamic and other connections with dorsal CA2 area of the mouse hippocampus. J Comp Neurol 521(8):1844–1866
Article
CAS
PubMed
PubMed Central
Google Scholar
Daniel SE, Lees AJ (1993) Parkinson’s disease society brain Bank, London: overview and research. J Neural Transm Suppl 39:165–172
CAS
PubMed
Google Scholar
Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen SH (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology AAN Enterprises 41(9):1402–1409
CAS
Google Scholar
Dickson DW, Schmidt ML, Lee VM, Zhao ML, Yen SH, Trojanowski JQ (1994) Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol 87(3):269–276
Article
CAS
PubMed
Google Scholar
Docherty MJ, Burn DJ (2010) Parkinson’s disease dementia. Curr Neurol Neurosci Rep 10(4):292–298
Article
PubMed
Google Scholar
Dudek SM, Alexander GM, Farris S (2016) Rediscovering area CA2: unique properties and functions. Nat Rev Neurosci 17(2):89–102.
Dugger BN, Dickson DW (2010) Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies. Acta Neuropathol 120(5):633–639
Article
CAS
PubMed
PubMed Central
Google Scholar
Emre M (2003) Dementia associated with Parkinson’s disease. Lancet Neurol 2(4):229–237
Article
CAS
PubMed
Google Scholar
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707
Article
PubMed
Google Scholar
Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Brayne C, Robbins TW, Barker RA (2011) The natural history of treated Parkinson’s disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry 82(10):1112–1118
Article
PubMed
Google Scholar
Foo H, Mak E, Chander RJ, Ng A, Au WL, Sitoh YY, Tan LCS, Kandiah N (2017) Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson’s disease. NeuroImage Clin 14:37–42
Article
PubMed
Google Scholar
Fujishiro H, Umegaki H, Isojima D, Akatsu H, Iguchi A, Kosaka K (2006) Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies. Acta Neuropathol 111(2):109–114
Article
PubMed
Google Scholar
Goldman JG, Williams-Gray C, Barker RA, Duda JE, Galvin JE (2014) The spectrum of cognitive impairment in Lewy body diseases. Mov Disord 29(5):608–621
Article
PubMed
PubMed Central
Google Scholar
Halgin R, Riklan M, Misiak H (1977) Levodopa, parkinsonism, and recent memory. J Nerv Ment Dis 164(4):268–272
Article
CAS
PubMed
Google Scholar
Hall H, Reyes S, Landeck N, Bye C, Leanza G, Double K, Thompson L, Halliday G, Kirik D (2014) Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson’s disease. Brain 137(9):2493-2508
Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson’s disease. Acta Neuropathol 115(4):409–415
Article
PubMed
Google Scholar
Halliday GM, Cullen K, Cairns MJ (1993) Quantitation and three-dimensional reconstruction of Ch4 nucleus in the human basal forebrain. Synapse 15(1993):1–16
Article
CAS
PubMed
Google Scholar
Harding AJ, Lakay B, Halliday GM (2002) Selective hippocampal neuron loss in dementia with Lewy bodies. Ann Neurol 51(1):125–128
Article
PubMed
Google Scholar
Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844
Article
PubMed
Google Scholar
Hietanen M, Teräväinen H (1988) Dementia and treatment with L-dopa in Parkinson’s disease. Mov Disord 3(3):263–270
Article
CAS
PubMed
Google Scholar
Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kövari E (2013) Neuropathology of dementia in a large cohort of patients with Parkinson’s disease. Parkinsonism Relat Disord Elsevier Ltd 19(10):864–868
Article
Google Scholar
Howlett DR, Whitfield D, Johnson M, Attems J, O’Brien JT, Aarsland D, Lai MKP, Lee JH, Chen C, Ballard C, Hortobágyi T, Francis PT (2015) Regional multiple pathology scores are associated with cognitive decline in Lewy body dementias. Brain Pathol 25(4):401–408
Article
CAS
PubMed
Google Scholar
Hyman B, Van Hoesen G, Damasio A, Barnes C (1984) Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science (80- ) 225(4667):1168–1170
Article
CAS
Google Scholar
Hyman BT, Kromer LJ, Van Hoesen GW (1987) Reinnervation of the hippocampal perforant pathway zone in Alzheimer’s disease. Ann Neurol 21(3):259–267
Article
CAS
PubMed
Google Scholar
Ince PG, Holton JL, Revesz T, Wharton SB (2008) Diseases of movement and system degenerations. In: Love S, Louis DN, Ellison DW (eds) Greenfield’s neuropathology, 8th edn. Hodder Arnold, pp 889–1030
Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM-Y, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72(4):587–598
Article
CAS
PubMed
PubMed Central
Google Scholar
Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115(4):427–436
Article
PubMed
Google Scholar
Kai H, Shin R-W, Ogino K, Hatsuta H, Murayama S, Kitamoto T (2012) Enhanced antigen retrieval of amyloid β immunohistochemistry: re-evaluation of amyloid β pathology in Alzheimer disease and its mouse model. J Histochem Cytochem 60(10):761–769
Article
PubMed
PubMed Central
CAS
Google Scholar
Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RKB, Gentleman SM (2009) Dementia and visual hallucinations associated with limbic pathology in Parkinson’s disease. Parkinsonism Relat Disord. Elsevier Ltd 15(3):196–204
Article
CAS
Google Scholar
Kalaitzakis ME, Pearce RKB (2009) The morbid anatomy of dementia in Parkinson’s disease. Acta Neuropathol 118(5):587–598
Article
CAS
PubMed
Google Scholar
Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson’s disease. Acta Neuropathol 106(1):83–88
PubMed
Google Scholar
Lees AJ, Hardy J, Revesz T (2009) Parkinson’s disease. Lancet Elsevier Ltd 373(9680):2055–2066
Article
CAS
Google Scholar
Leroi I, Brandt J, Reich SG, Lyketsos CG, Grill S, Thompson R, Marsh L (2004) Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson’s disease. Int J Geriatr Psychiatry. John Wiley & Sons, Ltd 19(1):1–8
Article
PubMed
Google Scholar
Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM-Y, Leverenz JB, Masliah E, IG MK, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK, DLB/PDD Working Group (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68(11):812–819
Article
CAS
PubMed
Google Scholar
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society task force guidelines. Mov Disord 27(3):349–356
Article
PubMed
PubMed Central
Google Scholar
Liu AKL, Lim EJ, Ahmed I, Chang RC-C, Pearce RKB, Gentleman SM (2018) Review: revisiting the human cholinergic nucleus of the diagonal band of Broca. Neuropathol Appl Neurobiol 44(7):647–662
Article
CAS
PubMed
PubMed Central
Google Scholar
Mankin EA, Diehl GW, Sparks FT, Leutgeb S, Leutgeb JK (2015) Hippocampal CA2 activity patterns change over time to a larger extent than between spatial contexts. Neuron 85(1):190–201
Article
CAS
PubMed
PubMed Central
Google Scholar
Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease. Acta Neuropathol 100(3):285–290
Article
CAS
PubMed
Google Scholar
McEwen BS (1997) Magarinos a M. stress effects on morphology and function of the hippocampus. Ann N Y Acad Sci 821:271–284
Article
CAS
PubMed
Google Scholar
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Kosaka K et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology. 89(1):88–100
Article
PubMed
PubMed Central
Google Scholar
Mesulam MM, Mufson EJ, Levey AI, Wainer BH (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214(2):170–197
Article
CAS
PubMed
Google Scholar
Milner TA, Bacon CE (1989) Ultrastructural localization of tyrosine hydroxylase-like immunoreactivity in the rat hippocampal formation. J Comp Neurol 281(3):479–495
Article
CAS
PubMed
Google Scholar
Novellino F, Vasta R, Alessia S, Chiriaco C, Maria S, Maurizio M, Gennarina A, Saccà V, Nicoletti G, Quattrone A (2017) Relationship between hippocampal subfields and category cued recall in AD and PDD: a multimodal MRI study. Neuroscience.
Pang CC-C, Kiecker C, O’Brien JT, Noble W, Chang RC-C (2018) Ammon’s horn 2 (CA2) of the Hippocampus: a long-known region with a new potential role in neurodegeneration. Neuroscientist :1073858418778747
Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson’s disease: comparisons with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 48(5):413–421
Article
CAS
PubMed
PubMed Central
Google Scholar
Ransmayr G, Cervera P, Hirsch E, Ruberg M, Hersh LB, Duyckaerts C, Hauw J-J, Delumeau C, Agid Y (1989) Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer’s disease. Neuroscience. 32(3):701–714
Article
CAS
PubMed
Google Scholar
Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson’s disease. Brain 132(Pt 11):2947–2957
Article
CAS
PubMed
Google Scholar
Tsuboi Y, Dickson DW (2005) Dementia with Lewy bodies and Parkinson’s disease with dementia: are they different? Parkinsonism Relat Disord 11(Suppl 1):S47–S51
Article
PubMed
Google Scholar
World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
Google Scholar
Zola-Morgan S, Squire LR, Amaral DG (1986) Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 6(10):2950–2967
Article
CAS
PubMed
Google Scholar